Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Biologics, Radiopharmaceuticals and Genetic Therapies - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 217922
Later capture
Biologics, Radiopharmaceuticals and Genetic Therapies - Canada.ca
Jan 2, 2026
hc-20260101
ID 429116
updated1 sections changed
1 sections changed0 added0 removed+1 / -2 linesChange ratio: 7%
--- +++ @@ -18,5 +18,4 @@ Summary Basis of Decision documents are available, which outline the scientific and benefit/risk based decisions that factor into Health Canada's decision to grant market authorization for a drug or medical device. Page details-Date modified:-2015-05-13+2017-05-04